Mamputu相关文献与解析，生知库 | 链接生命科学的每一步

Weatherald, Jason; Provencher, Steeve; Murray, Jillian; Badin, Matthew; Golden, Shane; Mielniczuk, Lisa; Swiston, John; Zhang, Chang; Yip, Cindy Y Y; Mamputu, Jean-Claude; Millson, Brad

肺动脉高压

心血管

发表日期：2026

文献求助收藏

Tesamorelin improves fat quality independent of changes in fat quantity

Tesamorelin 可改善脂肪质量，且与脂肪数量的变化无关。

期刊:AIDS

影响因子:3.4

doi:10.1097/QAD.0000000000002897.

Jordan E Lake,Kristen La,Kristine M Erlandson,Stefan Adrian,Gayane Yenokyan,Ann Scherzinger,Michael P Dubé,Takara Stanley,Steven Grinspoon,Julian Falutz,Jean-Claude Mamputu,Christian Marsolais,Grace A McComsey,Todd T Brown

Visceral fat reduction with tesamorelin is associated with improved liver enzymes in HIV

使用特沙莫瑞林减少内脏脂肪与HIV感染者肝酶水平改善相关。

期刊:AIDS

影响因子:3.4

doi:10.1097/QAD.0000000000001614.

Lindsay T Fourman,Natalia Czerwonka, Meghan N Feldpausch, Julian Weiss, Jean-Claude Mamputu, Julian Falutz, Josée Morin, Christian Marsolais, Takara L Stanley, Steven K Grinspoon

炎症/感染

发表日期：2017

文献求助收藏

Predictors of Treatment Response to Tesamorelin, a Growth Hormone-Releasing Factor Analog, in HIV-Infected Patients with Excess Abdominal Fat

预测HIV感染合并腹部脂肪过多患者对生长激素释放因子类似物替沙莫林治疗反应的因素

期刊:PLoS One

影响因子:2.6

doi:10.1371/journal.pone.0140358

Mangili, Alexandra; Falutz, Julian; Mamputu, Jean-Claude; Stepanians, Miganush; Hayward, Brooke

Reduction in visceral adiposity is associated with an improved metabolic profile in HIV-infected patients receiving tesamorelin

接受特沙莫瑞林治疗的 HIV 感染患者，内脏脂肪减少与代谢状况改善相关。

期刊:Clinical Infectious Diseases

影响因子:8.2

doi:10.1093/cid/cis251.

Takara L Stanley,Julian Falutz, Christian Marsolais, Josée Morin, Graziella Soulban, Jean-Claude Mamputu, Hani Assaad, Ralph Turner, Steven K Grinspoon

代谢

发表日期：2012

文献求助收藏

Effects of tesamorelin on inflammatory markers in HIV patients with excess abdominal fat: relationship with visceral adipose reduction

替沙莫林对伴有腹部脂肪过多的HIV患者炎症标志物的影响：与内脏脂肪减少的关系

期刊:AIDS

影响因子:3.4

doi:10.1097/QAD.0b013e328347f3f1.

Takara L Stanley,Julian Falutz, Jean-Claude Mamputu, Graziella Soulban, Diane Potvin, Steven K Grinspoon

Real-world Persistence on Selexipag for Pulmonary Arterial Hypertension in Canada

加拿大肺动脉高压患者使用司来帕格治疗的真实世界疗效

Tesamorelin improves fat quality independent of changes in fat quantity

Tesamorelin 可改善脂肪质量，且与脂肪数量的变化无关。

Visceral fat reduction with tesamorelin is associated with improved liver enzymes in HIV

使用特沙莫瑞林减少内脏脂肪与HIV感染者肝酶水平改善相关。

Predictors of Treatment Response to Tesamorelin, a Growth Hormone-Releasing Factor Analog, in HIV-Infected Patients with Excess Abdominal Fat

预测HIV感染合并腹部脂肪过多患者对生长激素释放因子类似物替沙莫林治疗反应的因素

Reduction in visceral adiposity is associated with an improved metabolic profile in HIV-infected patients receiving tesamorelin

接受特沙莫瑞林治疗的 HIV 感染患者，内脏脂肪减少与代谢状况改善相关。

Effects of tesamorelin on inflammatory markers in HIV patients with excess abdominal fat: relationship with visceral adipose reduction

替沙莫林对伴有腹部脂肪过多的HIV患者炎症标志物的影响：与内脏脂肪减少的关系